Multivariate analysis for risk factors associated with damage accrual in patients with SLE.
| Variables | OR (95% CI) | p |
|---|---|---|
| Age, yrs, at baseline | 1.05 (1.023, 1.072) | < 0.0001 |
| Being female | 0.41 (0.192, 0.901) | 0.0261 |
| White | 1.74 (0.905, 3.342) | 0.0970 |
| Ever used azathioprine in the first 3 yrs | 1.67 (0.814, 3.415) | 0.1625 |
| AMS in the first 3 yrs | 1.11 (1.010, 1.231) | 0.0305 |
| Steroid — cumulative dose in the first 3 yrs | 1.07 (1.029, 1.108) | 0.0006 |
| Used HCQ in the first 3 yrs | 0.34 (0.139, 0.838) | 0.0190 |
SLE: systemic lupus erythematosus; AMS: adjusted mean SLEDAI; SLEDAI: Systemic Lupus Erythematosus Disease Activity Index; HCQ: hydroxychloroquine.